STXS (Stereotaxis) Moat Score: 4/10 (As of Jun. 29, 2026)


STXS Stereotaxis Inc STXS
66 GF Score
Price $1.73
GF Value $2.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Moat Score?

Stereotaxis STXS +2.98% 66 Moat Score is 4 as of Jun. 29, 2026. GuruFocus rates STXS with a GF Score™ of 66/100 and a GF Value™ of $2.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Stereotaxis ranks better than 83.33% on this metric.

Stereotaxis has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Stereotaxis has Narrow Moat: Stereotaxis Inc has a discernible moat due to its innovative technology in robotic surgery systems. It benefits from intellectual property and some customer loyalty, but lacks strong market leadership, regulatory barriers, and network effects to elevate it to a stronger moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Stereotaxis might have Narrow Moat - Discernible but modest moat.

Stereotaxis  (AMEX:STXS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Stereotaxis Moat Score Related Terms

STXS vs PDEX, KRMD, EMBC: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stereotaxis Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Moat Score distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Moat Score falls into.


STXS
66GF Score
Stereotaxis Inc STXS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Stereotaxis (STXS) has a Moat Score of 4 as of Jun. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Stereotaxis ranks #141 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Stereotaxis' Moat Score too high?
Stereotaxis' current Moat Score is 4. Based on the distribution chart, Stereotaxis ranks #141 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stereotaxis has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' Moat Score compare to PDEX and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Stereotaxis ranks #141 out of 846 companies for Moat Score. This places Stereotaxis in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Stereotaxis's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.31, compared to a current price of $1.73 — trading 25.1% below its estimated fair value. The current Moat Score is 4. Stereotaxis' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Stereotaxis (STXS), the current Moat Score is 4 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.73 is trading 25.1% below its estimated GF Value™ of $2.31. GuruFocus considers Stereotaxis to be Modestly Undervalued.

Key valuation signals for STXS:

  • Moat Score: 4
  • GF Value™: $2.31 vs. price of $1.73 (25.1% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
66GF Score

Get the complete analysis for STXS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.73
Price
$2.31
GF Value